oxymatrine has been researched along with Pulmonary Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Hu, J; Liao, D; Mo, Z; Sun, R; Yang, Z; Zhong, N | 1 |
| Li, Z; Liu, L; Lu, W; Ma, Z | 1 |
2 other study(ies) available for oxymatrine and Pulmonary Fibrosis
| Article | Year |
|---|---|
Attenuation of bleomycin-induced lung fibrosis by oxymatrine is associated with regulation of fibroblast proliferation and collagen production in primary culture.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bleomycin; Cell Proliferation; Cells, Cultured; Collagen; Dose-Response Relationship, Drug; Fibroblasts; Hydroxyproline; Lipid Peroxidation; Lung; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Quinolizines | 2008 |
Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antiviral Agents; Bleomycin; Lung; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Peroxidase; Pulmonary Fibrosis; Quinolizines; Signal Transduction; Smad Proteins; Sophora; Transforming Growth Factor beta | 2012 |